about
Oral pathology in inflammatory bowel diseaseOptimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug WithdrawalBest practice in primary care pathology: review 10.Pancytopenia induced by low-dose methotrexate. A study of the cases reported to the Finnish Adverse Drug Reaction Register From 1991 to 1999.Low-dose methotrexate-induced pancytopenia.Methotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children.Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.Neutropenia in the Elderly: A Rheumatology Perspective.Methotrexate and bone marrow suppression: drug errors may be implicated in death.Methotrexate and bone marrow suppression: standard collaborative care will be made more difficultMyelotoxicity due to methotrexate - an iatrogenic cause.Methotrexate and oral ulceration.RETRACTED ARTICLE: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report.Severe acute pancytopaenia in a patient with rheumatoid arthritis complicated by fatal invasive pulmonary aspergillosis.Methotrexate-induced pancytopenia in a patient with ectopic pregnancy.Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment
P2860
Q26739055-C3CEDC57-5386-457B-9410-B7716BC7D50FQ26801119-A91783C5-3E86-4B77-A3A3-235407E63662Q36172237-0657FB50-05FD-4FA0-A14F-33F3512E1BCBQ36245715-07A5E947-B45D-4917-82E4-94F249AC2191Q36459197-318B3C89-C373-4918-91E5-9205235571C2Q37871863-44152878-0903-415C-B0CC-2608C8AFFA30Q38741861-5B79F987-4684-4F12-84FF-CB16BA46F5C8Q38893238-E3BD5A0F-0B64-4D5E-8B6A-934CC349990EQ42385936-39A22EC5-6AC3-4559-B4A7-DD4CAD5A24D0Q42385943-ECBC608A-C86F-4B4E-ABF8-2E59E02C38C4Q44569940-0EFFCBDB-1228-4374-9316-BCFF3F6FE1FEQ45258407-69AAAC86-787E-4CA1-83D3-159CACF08CC2Q48615436-5EC78A4D-26F3-442D-AF9D-BF25F8C876D0Q52947070-60A5030E-2AA7-4BF0-9466-084F33E8782CQ55070948-362B30FE-9D76-41E1-A27F-628471878D2DQ58777594-171EFDF9-A116-4AC8-A04E-217EC95EF616
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Low dose methotrexate and bone marrow suppression.
@ast
Low dose methotrexate and bone marrow suppression.
@en
type
label
Low dose methotrexate and bone marrow suppression.
@ast
Low dose methotrexate and bone marrow suppression.
@en
prefLabel
Low dose methotrexate and bone marrow suppression.
@ast
Low dose methotrexate and bone marrow suppression.
@en
P2860
P356
P1433
P1476
Low dose methotrexate and bone marrow suppression.
@en
P2093
Michael Sosin
Sunil Handa
P2860
P304
P356
10.1136/BMJ.326.7383.266
P407
P577
2003-02-01T00:00:00Z